行情

ANIK

ANIK

阿尼卡医疗
NASDAQ

实时行情|Nasdaq Last Sale

60.23
+0.01
+0.02%
盘后: 60.23 0 0.00% 16:06 11/11 EST
开盘
60.01
昨收
60.22
最高
60.54
最低
59.31
成交量
13.08万
成交额
--
52周最高
75.72
52周最低
29.01
市值
8.59亿
市盈率(TTM)
27.83
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ANIK 新闻

  • 沪指高开震荡 金价连续多日走低
  • 新浪财经.17分钟前
  • 美“星链”计划第二批60颗卫星成功发射 创两项纪录
  • 新华网.2小时前
  • 苹果重组网络视频业务 Apple TV+内容主管将离职
  • 新浪科技.3小时前
  • Apple Card被投诉 大亨为啥也在乎信用额度
  • 财新网.4小时前

更多

所属板块

制药
-0.42%
制药与医学研究
-0.41%

热门股票

名称
价格
涨跌幅

ANIK 简况

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
展开

Webull提供Anika Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。